Furthermore, the risk of BC was raised in OC patients with BRCA1/BRCA2 mutations, and the incidence of BC varied from 3.9 percent to 10.98 percent in those women [13, 16, 17]. This evidence concerns the gene BRCA1 and breast cancer.